digital health investment

Debiopharm is an independent biopharmaceutical company based in Switzerland, committed to developing tomorrow's standard of care to cure cancer and infectious diseases and improve patient quality of life. Its main activities include drug development, drug manufacturing and digital health investment. Founded in 1979 by Dr. Rolland-Yves Mauvernay, it is now a group of three companies: Debiopharm International (drug development), Debiopharm Research & Manufacturing (drug manufacturing) and Debiopharm Innovation Fund (digital health investment). It is the Li

Read more

drug developmentdrug manufacturingin-licensing and out-licensing of compoundsresearch & development